Cargando…

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial

Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruttens, David, Verleden, Stijn E., Demeyer, Heleen, Van Raemdonck, Dirk E., Yserbyt, Jonas, Dupont, Lieven J., Vanaudenaerde, Bart M., Vos, Robin, Verleden, Geert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889063/ https://www.ncbi.nlm.nih.gov/pubmed/29624575 http://dx.doi.org/10.1371/journal.pone.0193564

Ejemplares similares

Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation
por: Vanstapel, Arno, et al.
Publicado: (2021)

LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats
por: Tu, Zheng-Liang, et al.
Publicado: (2017)

The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome
por: Goos, Tinne, et al.
Publicado: (2022)

Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
por: Stijn, Willems, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019)

Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs
por: Einarsson, Gisli G., et al.
Publicado: (2022)

Optimizing future lung transplant outcomes: asking the right questions for an alternative truth
por: Vos, Robin, et al.
Publicado: (2020)

Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation
por: Suwara, Monika I, et al.
Publicado: (2014)

Peripheral Blood Eosinophilia Is Associated with Poor Outcome Post-Lung Transplantation
por: Kaes, Janne, et al.
Publicado: (2020)

Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions
por: Glanville, Allan R., et al.
Publicado: (2022)

The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
por: Jones, Christopher A., et al.
Publicado: (2016)

Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks
por: De Vleeschauwer, Stéphanie, et al.
Publicado: (2012)

A novel experimental porcine model to assess the impact of differential pulmonary blood flow on ischemia–reperfusion injury after unilateral lung transplantation
por: Frick, Anna Elisabeth, et al.
Publicado: (2021)

The common rejection module in chronic rejection post lung transplantation
por: Sacreas, Annelore, et al.
Publicado: (2018)

Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model
por: Martens, An, et al.
Publicado: (2017)

Therapeutic effect of budesonide, montelukast and azithromycin on post-infectious bronchiolitis obliterans in children
por: Chen, Xia, et al.
Publicado: (2020)

Lung Transplantation and Precision Medicine
por: Beeckmans, Hanne, et al.
Publicado: (2019)

Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
por: Delanote, Isabelle, et al.
Publicado: (2016)

A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury
por: Martens, An, et al.
Publicado: (2017)

Bronchiolitis obliterans
por: King, Talmadge E.
Publicado: (1989)

Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
por: Goos, Tinne, et al.
Publicado: (2021)

Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis
por: Vanstapel, Arno, et al.
Publicado: (2021)

CT-based Machine Learning for Donor Lung Screening Prior to Transplantation
por: Ram, Sundaresh, et al.
Publicado: (2023)

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
por: Kim, Sei Won, et al.
Publicado: (2016)

Successful double-lung transplantation from a donor previously infected with SARS-CoV-2
por: Ceulemans, Laurens J, et al.
Publicado: (2021)

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival
por: Yang, Joshua Y.C., et al.
Publicado: (2019)

Flow-controlled ventilation during EVLP improves oxygenation and preserves alveolar recruitment
por: Ordies, Sofie, et al.
Publicado: (2020)

Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation
por: Yu, Jinho
Publicado: (2015)

Commentary: Donor lungs allocated to critically ill patients listed urgently: No longer a waste of precious organs?
por: Van Raemdonck, Dirk, et al.
Publicado: (2021)

Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation
por: Lin, Christine M., et al.
Publicado: (2014)

Thin-section Computed Tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction
por: de Jong, Pim A., et al.
Publicado: (2011)

Azole-Induced Myositis after Combined Lung-Liver Transplantation
por: Happaerts, Sofie, et al.
Publicado: (2022)

Off-pump lung re-transplantation avoiding clamshell thoracotomy is feasible and safe: a single-center experience
por: Jin, Xin, et al.
Publicado: (2023)

Lung volume reduction in emphysema: a pragmatic prospective cohort study
por: Dooms, Christophe, et al.
Publicado: (2021)

Clinical analysis of adenovirus postinfectious bronchiolitis obliterans and nonadenovirus postinfectious bronchiolitis obliterans in children
por: Huang, Fei, et al.
Publicado: (2021)

Aspergillus-Specific IgG Antibodies are Associated With Fungal-Related Complications and Chronic Lung Allograft Dysfunction After Lung Transplantation
por: Beeckmans, Hanne, et al.
Publicado: (2023)

Lung Transplant Outcome From Selected Older Donors (≥70 Years) Equals Younger Donors (<70 Years): A Propensity-matched Analysis
por: Vanluyten, Cedric, et al.
Publicado: (2023)

A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome
por: Van Slambrouck, Jan, et al.
Publicado: (2022)

Follow-up on the therapeutic effects of a budesonide, azithromycin, montelukast, and acetylcysteine (BAMA) regimen in children with post-infectious bronchiolitis obliterans
por: Weng, Tingting, et al.
Publicado: (2021)

The impact of endoscopic lung volume reduction on physical activity coaching in patients with severe emphysema
por: Blondeel, Astrid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ibtudc7hqnqtmt2tjg46t73ue7